Research venture capital in Israel by matching entry stage, technical thesis and first customer market. A pre-seed infrastructure team, a cybersecurity startup and a growth-stage software business need different evidence and may belong with different funds inside the same investment group.
This guide compares 15 selected Israel-linked firms and platforms. It adds a national decision framework to our Tel Aviv city research, distinguishes company creation from investment in an existing startup, and keeps international offices separate from eligibility. Use it to build a defensible shortlist, not to rank investors by reputation or send the same deck to everyone.
Select the financing route before the investor name
- Define the company's next proof. Technical validation, practitioner adoption, first revenue and repeatable expansion are different milestones.
- Identify the actual investment arm. Early equity, growth equity, credit and venture creation are not interchangeable.
- Specify the founder and market connection. Record the operating team, customers and relevant geographic mandate without assuming an office creates eligibility.
- Check the current public process. A platform, advisory board or portfolio logo is not an allocation, application approval or promised introduction.
Compare 15 Israeli investor routes
Use provider type, stage and geographic connection together. An office address is not a promise of eligibility. Where the current source does not establish a precise entry stage, the table leaves that question open.
Selected Israel-linked venture firms and clearly distinguished investment platforms, researched October 29, 2026. This is a fit comparison, not a performance ranking. On small screens, scroll the table sideways to see every column.
| Investor or network | Provider type | Stage | Sector focus | Geographic connection |
|---|---|---|---|---|
| Pitango | Multi-strategy venture platform | Seed and early; venture growth; separate HealthTech stages | AI; quantum; cloud; cyber; health and life sciences | Israeli roots with global company-building reach |
| Aleph | Early-stage venture firm | Early-stage; confirm the current entry round | Technology-led global company building | Explicit focus on Israeli entrepreneurs building global businesses |
| TLV Partners | Early-stage venture firm | Day-zero and early-stage; later support differs | Technology; current examples span AI, infrastructure, cyber and health | Backs Israeli founders with global ambitions |
| Team8 | Venture firm and company-creation platform | Seed and Series A investment; creation is a separate route | Cybersecurity; software infrastructure; fintech; digital health | Tel Aviv headquarters and New York presence |
| Viola Group | Multi-strategy technology investment group | Inception to growth, through independent investment arms | Technology; dedicated fintech and credit strategies | Israeli entrepreneur and global technology-company focus |
| Glilot Capital Partners | Cybersecurity and AI venture platform | G-Seed at inception; G+ at Series A/B | Cybersecurity and AI | Israel-linked venture platform; confirm the relevant fund's mandate |
| Grove Ventures | Early-stage technology venture firm | Pre-seed and seed | Enterprise AI; deep tech; AI infrastructure; healthtech | Early partner to Israeli founding teams |
| Entrée Capital | International venture firm | Confirm the current fund and entry round | AI; deep technology; enterprise; fintech and related themes | Tel Aviv, London and New York office network |
| Vertex Ventures Israel | Israel venture firm | Seed through Series B | AI; cybersecurity; healthtech; deep tech | Israel strategy within the wider Vertex network |
| F2 Venture Capital | Early-stage venture firm | Early-stage; zero-to-one company development | Technology; confirm the specific partner and thesis | Explicit focus on Israeli founders and startups out of Israel |
| YL Ventures | Specialist cybersecurity venture firm | Inception and seed, with support toward scale | Cybersecurity | Israel-linked cybersecurity founders and international customer markets |
| Jerusalem Venture Partners | Early- and growth-stage venture platform | Early and growth strategies | Cyber; enterprise data and AI; fintech; insurtech; climate | Thematic centers in Israel and New York |
| StageOne Ventures | Enterprise deep-tech venture firm | Seed and company inception | Complex enterprise technology and deep tech | Explicit Israel-related entrepreneur mandate |
| 10D | Early-stage venture firm | Early-stage; confirm the specific round | Technology-led businesses; company-specific | Explicit focus on early-stage Israeli entrepreneurs |
| Hanaco Ventures | Venture firm spanning early and growth companies | Early through growth; strategy-specific | Technology businesses; confirm current sector fit | Rooted in the Israeli ecosystem; Tel Aviv to New York network |
National fit is broader than a Tel Aviv address
Several firms explicitly describe Israeli or Israel-related founders, while others connect investment teams in Israel with international customer markets. That is a different research job from choosing investors with a local office near the founding team.
For each candidate, record three separate facts: the manager's presence, the published investment remit and your company's connection. Ask how the specific fund evaluates a distributed team or overseas commercial operation. Do not infer company eligibility, incorporation requirements or tax consequences from a directory entry.
A cybersecurity thesis is not a general AI mandate
YL Ventures is a cybersecurity specialist. Glilot currently describes cybersecurity and AI, with distinct seed and Series A/B strategies. Team8 separates four domains and two company-building routes. An AI-enabled feature alone does not establish fit with any of them.
Prepare a practitioner problem, the failure being prevented, evidence from real use and the path through security or enterprise procurement. For infrastructure, health or deep-tech investors, replace that proof pack with the relevant performance, validation and adoption evidence. Do not reuse an enterprise-software pitch unchanged for a research-intensive product.
One investment group can contain several different answers
Pitango distinguishes First, Growth and HealthTech. Viola describes independent investment arms, including credit and fintech. Vertex's Israel fund should not be conflated with other geography-specific funds in its network.
Keep one manager-level directory record, then record the actual vehicle and decision-making team in your working shortlist. That avoids counting the same organization repeatedly while preserving the distinctions that matter for a financing conversation. The round label alone is not a complete match.
Build a proof pack that bridges technology and customers
StageOne emphasizes difficult enterprise technology. Grove names enterprise AI, deep tech, AI infrastructure and healthtech. TLV's current company examples span several technical fields. These themes are useful filters, not substitutes for a concrete case.
- Technical proof: what works, under which conditions, and what remains unvalidated?
- Customer proof: who has used or bought the product, and what problem changed?
- Financing proof: which milestone does the next capital unlock, and how will progress be judged?
- Market proof: what must be repeated or adapted outside the first customer segment?
Investor profiles and official routes
These profiles are a research aid, not a performance ranking. Read the current strategy and portfolio before sharing a deck. A public contact route does not establish that a firm has available allocation for your round.
Pitango
Multi-strategy venture platform. Israeli roots with global company-building reach. Choose Pitango First, Growth or HealthTech before evaluating fit. The current strategy separates early company development, venture growth and health-related investment. A research-intensive team should connect technical validation to the next commercial milestone. Count the manager once, not once for every fund or portfolio company.
Pitango: official investment information · Contact Us
Aleph
Early-stage venture firm. Explicit focus on Israeli entrepreneurs building global businesses. Aleph's current About page connects its early-stage strategy to Israeli entrepreneurs and international business building. Prepare the company's insight, first customer evidence and global-market case. Ampliphy is described as an internal support operation, not another investor to count. The public page does not establish cheque size or available allocation.
Aleph: official investment information
TLV Partners
Early-stage venture firm. Backs Israeli founders with global ambitions. TLV's current proposition starts with Israeli founders at day zero and supports company development beyond the initial stage. Separate the round you are raising from later outcomes in its portfolio. Explain what the founding team knows, what the product proves today and which customer question remains unresolved.
TLV Partners: official investment information
Team8
Venture firm and company-creation platform. Tel Aviv headquarters and New York presence. Team8's venture-capital page distinguishes backing an existing company from building a company together. An independent founding team should identify the appropriate investment route rather than assuming a venture-creation program is a conventional funding application. Prepare domain-specific product and customer validation, not only a broad AI narrative.
Team8: official investment information · Additional official strategy or location evidence
Viola Group
Multi-strategy technology investment group. Israeli entrepreneur and global technology-company focus. Viola Ventures, Growth, Credit and Fintech have separate teams and pools of capital. Record the actual arm before assigning a round or instrument. Early-stage equity, expansion capital, credit and a feeder product for investors solve different jobs. This directory counts the group once while preserving those distinctions for a founder's next research step.
Viola Group: official investment information · Contact us
Glilot Capital Partners
Cybersecurity and AI venture platform. Israel-linked venture platform; confirm the relevant fund's mandate. The current site distinguishes G-Seed from G+ and describes separate company-building support. Select the right financing stage, then explain the security or AI operating problem and evidence from buyers. Mach5 support and G-Club wealth services are not extra independent startup funds or automatic customer introductions.
Glilot Capital Partners: official investment information · Contact Us
Grove Ventures
Early-stage technology venture firm. Early partner to Israeli founding teams. Grove states its initial pre-seed and seed focus directly. A technical team should show the underlying advantage, who needs it and what capital will validate next. Its founder tools, talent resources and operating support complement the investment proposition; they should not be counted as separate capital commitments.
Grove Ventures: official investment information · Contact
Entrée Capital
International venture firm. Tel Aviv, London and New York office network. Entrée's current site connects several technology strategies with a cross-border office network. Identify the specific fund, team and market connection rather than treating every office as a promise of local eligibility. A global company story should still specify the first buyer, technical proof and execution milestone.
Entrée Capital: official investment information
Vertex Ventures Israel
Israel venture firm. Israel strategy within the wider Vertex network. Use the Israel team's published strategy rather than transferring criteria from another Vertex geography. Explain why the company fits the round and technology remit. The network includes distinct funds, and a portfolio company's later financing does not establish the entry cheque or process for a new applicant.
Vertex Ventures Israel: official investment information · Contact
F2 Venture Capital
Early-stage venture firm. Explicit focus on Israeli founders and startups out of Israel. F2's current proposition is to back Israeli founders early and help develop the business from zero to one. State the actual product and buyer, not just the category label. Its Operator Platform is support around company building, not a separate fund or an unconditional entitlement to customers or financing.
F2 Venture Capital: official investment information
YL Ventures
Specialist cybersecurity venture firm. Israel-linked cybersecurity founders and international customer markets. YL is a specialist route for a security company, not a general investor for every product using AI. Prepare a clear security problem, practitioner evidence and a credible path to adoption. Advisory relationships and CISO engagement are part of its operating approach, not introductions a new applicant can assume will occur.
YL Ventures: official investment information
Jerusalem Venture Partners
Early- and growth-stage venture platform. Thematic centers in Israel and New York. JVP connects early and growth investment with sector-specific centers. Explain which technical and market question the company solves before selecting a center or team. A thematic hub, commercial partnership and equity financing remain different relationships. Do not turn historic exits or portfolio valuations into a claim about a new applicant's outcome.
Jerusalem Venture Partners: official investment information · Contact us
StageOne Ventures
Enterprise deep-tech venture firm. Explicit Israel-related entrepreneur mandate. StageOne states its early-stage enterprise focus and Israel-related founder connection. Show the technological barrier, the enterprise user and the validation required before repeatable sales. A globally distributed team should clarify its actual connection and fund fit rather than treating an address as an eligibility guarantee.
StageOne Ventures: official investment information · Contact
10D
Early-stage venture firm. Explicit focus on early-stage Israeli entrepreneurs. 10D describes a broad technology and business-model outlook rather than a narrow industry checklist. Explain the company's competitive advantage and why the timing matters. References to later fundraising support are not a promise to finance every subsequent round or introduce a particular investor.
10D: official investment information
Hanaco Ventures
Venture firm spanning early and growth companies. Rooted in the Israeli ecosystem; Tel Aviv to New York network. Hanaco's current About page describes involvement across company stages and a link between Israel and wider markets. Specify the stage, market and operating challenge, then confirm the appropriate team and fund. Broad willingness to work with founders is not evidence that every industry, instrument or incorporation qualifies.
Hanaco Ventures: official investment information · Official contact route
A worked shortlist for an Israeli infrastructure team
Illustrative research exercise, not an investment recommendation. An Israeli founding team has a prototype that reduces enterprise AI deployment failures. Two design partners are testing it, but there is no repeatable sales motion. The next round would validate reliability and turn those tests into a clear buying case.
Different investor questions for the same fictional company
| Route | Research question | Evidence to prepare |
|---|---|---|
| Grove | Does the pre-seed/seed AI-infrastructure thesis fit? | Technical result, design-partner learning and next validation milestone. |
| StageOne | Is there a difficult enterprise technology barrier? | Architecture, integration constraints and defensibility. |
| Team8 Capital | Is this an existing startup for the venture-capital route? | Founding team, software-infrastructure fit and customer problem. |
| YL Ventures | Hold unless the central problem is cybersecurity | Do not re-label a reliability tool as security just to widen the shortlist. |
| Viola Growth | Hold the expansion strategy at this stage | A working prototype is not evidence of a growth-stage business. |
No named investor has evaluated this fictional company. Keep the open questions visible instead of assigning a false numerical probability of funding.
Copy your Israeli investor shortlist worksheet
Use one record for each investor and specific vehicle. Keep the source date beside your fit decision.
ISRAEL-LINKED INVESTOR FIT CARD
Company + next financing milestone: [facts]
Technical field + buyer: [specific problem]
Manager + investment arm: [name; current vehicle/team]
Entry stage: [published evidence or question]
Founder/operating connection: [team; customers; markets]
Current thesis: [official URL + checked date]
Evidence achieved: [technical; customer; commercial]
New market questions: [what is unvalidated]
Funding route: [equity / growth / credit / creation]
Decision + owner: [research / ask / hold; next action]Research the shortlist with Aurora, Claude or Codex
Give your AI teammate company facts you are authorized to share. Ask for sourced comparisons and open questions, not automatic introductions or outreach.
Be my Israel-focused investor-research teammate.
Company: [product, buyer and facts I may share]
Founding team and operating markets: [actual connections]
Next round: [stage and milestone to prove]
Candidates: [five managers or investment arms]
Check current official sources for stage, sector and geographic remit.
Separate venture creation, early equity, growth, credit and LP products.
For cyber or deep tech, identify the actual technical and customer proof.
Do not infer eligibility from an office or a portfolio logo.
Return source/date, fit evidence, missing proof and next research action.
Deduplicate managers and distinguish geography-specific fund teams.
Do not invent cheque sizes, open allocation, contacts or introductions.
Do not contact anyone, submit a deck or apply to a program.Keep the resulting investor records, relationship context and next actions together in Finta. The investor-prospecting workflow covers the next execution step.
Methodology, research date and local guides
Research checked October 29, 2026 by the Finta Editorial Team with AI-assisted source review. We reconciled provider names from our existing city research and reviewed current official strategy, portfolio, location or founder-contact pages. Firms with multiple offices count once; angel networks count as networks, not one committed pooled fund. We distinguish local presence from investment mandate and company eligibility. We do not infer check sizes, investor returns, lead behavior or open allocation from a portfolio logo.
We reused the existing Tel Aviv research for discovery, reconciled parent groups and distinct investment strategies, and added primary-source review for further Israel-linked firms. The national comparison focuses on the company-building and market questions that extend beyond a city address. Missing current criteria remain questions; we do not fill them from an old portfolio entry.
Informational purposes only. Finta is not a law firm or accounting firm. This is general fundraising information, not personalized financial, legal or tax advice. Discuss financing instruments, company structures, cross-border requirements and tax consequences with your attorney or accountant.
This is a selected research directory, not an exhaustive register or sponsored ranking. Confirm the current vehicle, team and process directly before relying on a fit decision.
Make the next fundraising step specific
Choose a small set of defensible matches, record the open question, and assign the next action. Use our investor-shortlist guide and warm-introduction guide to prepare the conversation. A longer list should make the research better, not turn into an indiscriminate mailing list.